section name header
Index
Acute Coronary Syndrome and Myocardial Infarction - Related Resources
Anticoagulants for Acute Ischaemic Stroke
Anticoagulants for Intermittent Claudication
Anticoagulants for Preventing Recurrence after Acute Ischaemic Stroke
Anticoagulant Therapy in Acute (Duration Less Than 48 Hours) Atrial Fibrillation
Anticoagulation for the Long Term Treatment of Venous Thromboembolism in Patients with Cancer
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and other Thromboembolic Events in People with Antiphospholipid Syndrome
Antiplatelet and Anticoagulation for Patients with Prosthetic Heart Valves
Antithrombotic Agents in Primary Health Care - Related Resources
Cardiology
Cardiovascular diseases
Changes of Bone Density after Exposure to Oral Anticoagulants
Clinical pharmacology
Cochrane review
Combined Aspirin-Oral Anticoagulant Therapy Compared with Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
Computerized Advice on Drug Dosage to Improve Prescribing Practice
Coronary Heart Disease - Related Resources
Direct Oral Anticoagulants
Direct Oral Anticoagulants Versus Vitamin K Antangonists in Non-Valvular Atrial Fibrillation
Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients with Chronic Kidney Disease
Dronedarone in Atrial Fibrillation
Endocrinology
Evidence summary
Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for First Episode of Venous Thromboembolism Vs Fatal Bleeding during Continued Anticoagulation
Gynaecology
Indications for and Implementation of Anticoagulant Therapy in Atrial Fibrillation - Related Resources
Internal medicine
Lower Limb Ischaemia - Related Resources
Low-Molecular-Weight Heparins (Lmwh) Versus Unfractionated Heparin for Venous Thromboembolism
Neurology
Noac Versus Warfarin Postpci in Atrial Fibrillation
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Oral Anticoagulation for Prolonging Survival in Patients with Cancer
Oral Direct Thrombin Inhibitors or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism
Osteoporosis - Related Resources
Pharmacology
Primary Prophylaxis for Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
Surgery
Systematic review
Tranexamic Acid in People on Anticoagulants Undergoing Minor Oral Surgery or Dental Extractions
Vascular surgery
Vitamin K Antagonists Versus Antiplatelet Therapy after TIA or Minor Ischaemic Stroke of Presumed Arterial Origin
Vitamin K for Improved Anticoagulation Control in Patients Receiving Warfarin
Warfarin for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Cerebral Ischaemia
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Warfarin Therapy - Related Resources